Mark Coleman - Director at Axsome Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Director
Issuer Symbol: AXSM on Nasdaq
All Insider Reports: All Insider Reports

Mark Coleman - trading volume in the past year for Axsome Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys	+1,575	13%	$127.28	+$200,466
Sells	-10,500	87%	$105.32	-$1,105,848
Net	-8,925	-74%		-$905,382

Holdings reported by Mark Coleman for Axsome Therapeutics, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	403,856	$75,933,005	$188.02	23 Feb 2026	Indirect
Common Stock	72,140	$357,093	$4.95	23 Feb 2026	Direct
Stock Option (Right to Buy)	7,721			23 Feb 2026	Direct	Common Stock
Restricted Stock Units	1,429			06 Jun 2025	Direct	Common Stock

Transactions reported by Mark Coleman for Axsome Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.